Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by CYBERPUNK on Aug 08, 2016 8:50am

Aggghhhh..

This could be worse than a downgrade.  Amber Kanwar tweets Mackie on Concordia:  "overpaid for weak assets...   debt to EV ratio is 85%... has an onerous and treacherous path going forward "  Plus other bad  stuff.  They are discontinuing coverage.
Comment by wallop13 on Aug 08, 2016 10:52am
Sounds like they are saying cover now. They were just taking one last shot on the way out. BNN said short position is down to 19% now.
Comment by CNInvesting on Aug 08, 2016 11:11am
Down 11% yeah... 1)Short interest report comes out tomorrow, so... 2) That would mean about 7.5 million shares were covered... I don't rememeber seeing that kind of volume from the buy-side lately. BNN keeps up with its tradition of spewing BS. Never mind what they say.
Comment by Lumberfeverlong on Aug 08, 2016 11:31am
Can anyone verify if and when Mackie took a short position on the stock?  They are a third tier firm.  I would not put too much credence in their analysis.  By their statements, they would have you beleive that there is no place in the market place for companies selling generic drugs, which we all know is complete BS as generic drug companies have played a major role in the ...more  
Comment by CNInvesting on Aug 08, 2016 11:38am
Agreed that their analysis has little weight to it. Also, it's a sell-side firm and in 2015 they were quite happy to rate CXR a buy when it was trading at 81$. Always a flipside.
Comment by sunshine7 on Aug 08, 2016 11:40am
 Yes, debt to EV 85% ... and dropping 5%/Q as CF seems adaquate to service and pay down.
Comment by GoldBug024 on Aug 08, 2016 12:49pm
Most biased reporter I've ever seen. Have you seen her coverage on real estate market? So one sided. Has mentioned numerous time her and her new hubby want to live in downtown TO but cant afford. Full disclosure I guess? LOL
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities